Background {#s1}
==========

Opportunistic infections represent a major cause of mortality in immunocompromised patients and are becoming more prevalent with the increased use of single and multi-agent immunosuppressive medications for treatment of immune-mediated and autoimmune diseases. Reports of opportunistic cutaneous infections in dogs associated with immunosuppression include *Nocardia* species ([@B1]), saprophytic fungi (phaeohyphomycosis and hyalohyphomycosis) ([@B2], [@B3]) and viral-induced papillomas ([@B4], [@B5]). Discontinuation of immunosuppressive medications is recommended with the development of opportunistic infections, which may cause a relapse or worsening of the immune-mediated disease ([@B3], [@B6]).

Herein, we describe successful treatment of cutaneous *Curvularia geniculata, Nocardia niigatensis* and viral papillomatosis with continued immunosuppression for treatment of immune-mediated hemolytic anemia (IMHA).

Case Presentation {#s2}
=================

A 7.5-year-old, 62 kg, female spayed Great Dane was referred for lethargy and anorexia. The initial complete blood count (CBC) and chemistry panel revealed a regenerative anemia with hyperbilirubinemia. Repeat CBC and chemistry profile revealed progressive regenerative anemia with spherocytosis and worsening hyperbilirubinemia confirming the diagnosis of IMHA. A comprehensive diagnostic IMHA work-up was performed to identify a possible underlying cause. A comprehensive tick panel, blood culture and urine culture were negative. A thoracic and abdominal CT scan did not identify an underlying cause. Three days later, the patient was started on oral twice daily mycophenolate mofetil (12 mg/kg AM and 8 mg/kg PM, MMF; Ascend Lab, LLC, Parsippany, NJ, USA). Due to worsening condition, the patient was hospitalized, received intravenous immunosuppression with MMF and dexamethasone, and received several multiple packed red blood cell transfusions. Due to lack of response to immunosuppressive therapies, a splenectomy was performed 2 weeks after initial presentation; histopathology report revealed fibrosis, congestion, hemosiderosis, and extramedullary hematopoiesis consistent with IMHA. Prior to discharge, about 3 weeks from initial presentation, the patient\'s IMHA treatment included oral twice daily MMF (12 mg/kg AM and 8 mg/kg PM), prednisone (0.5 mg/kg; West-ward Pharmaceuticals, Eatontown, NJ, USA), and ciclosporin (5 mg/kg; Elanco, Greenfield, NJ, USA).

The patient presented just over 6 weeks after initial referral with right forelimb paw swelling and multifocal draining tracts ([Figures 1a,b](#F1){ref-type="fig"}). With the patient receiving three immunosuppressive medications, differentials included an opportunistic fungal infection or bacterial infection. Skin cytology showed marked pyogranulomatous inflammation with non-staining, septate fungal hyphae. Punch biopsies of ulcerated skin lesions were submitted for fungal culture and routinely processed in paraffin wax and stained with hematoxylin and eosin (H&E) and Gomorimethenamine silver (GMS) fungal stain. Examination of H&E stained biopsies showed pyogranulomatous dermatitis with intralesional GMS-positive pigmented fungal elements, centered around hair follicles and adnexa, consistent with phaeohyphomycosis ([Figures 1c,d](#F1){ref-type="fig"}). Fungal culture grew a pigmented fungus and polymerase chain reaction (PCR) utilizing primers of internal transcribed spacer (ITS) D1/D2 regions from extracted fungal culture DNA produced a 1,085 bp band. The band sequencing and analysis using BLASTn search in GenBank revealed 99% sequence homology with *Curvularia geniculata*. Antifungal therapy was initiated with once daily oral terbinafine (32 mg/kg; Cipla USA, Sunrise, FL, USA) and itraconazole (5 mg/kg; PAR, Chestnut Ridge, NY, USA). The administration of immunosuppressive medications was modified; ciclosporin was immediately discontinued, prednisone was decreased (0.5 mg/kg AM and 0.3 mg/kg PM) and MMF lowered to once daily (12 mg/kg).

![Clinical and histopathology appearance of cutaneous *Curvularia geniculata*. Right forelimb paw swelling with multifocal draining tracts **(a,b)**; Note pyogranulomatous dermatitis with intralesional pigmented fungal elements (asterisk) centered around hair follicles and adnexa (**c**: 10X, H&E stain); Note the GMS-positive septate fungal elements, which form large, terminal dilations (**d**: 20X, GMS stain).](fvets-06-00249-g0001){#F1}

On progress examination, 4 weeks later (10 weeks from initial presentation), the right forelimb skin lesions completely resolved ([Figure 2a](#F2){ref-type="fig"}), but the patient developed acute diffuse upper left forelimb edema, nodules, and two draining tracts ([Figures 2a,b](#F2){ref-type="fig"}). Fine needle aspirate showed marked pyogranulomatous inflammation with rare multinucleated giant cells; there were no structures suggestive of bacterial or fungal infection. Skin biopsies were obtained and routinely processed in paraffin wax and stained with H&E, Gram, Giemsa, modified Ziehl--Neelsen (ZN), periodic acid--Schiff (PAS), and Warthin-Starry silver stain; fresh tissue from the affected lesional skin was submitted for fungal and bacterial aerobicculture. Histopathologic examination revealed marked diffuse neutrophilic dermatitis with superficial dermal edema and small numbers of macrophages ([Figures 2c,d](#F2){ref-type="fig"}). Argyrophilic, slender Gram- and Giemsa-stain positive branching bacilli were scattered throughout the deep dermis with neutrophilic infiltration ([Figure 2e](#F2){ref-type="fig"}); PAS and modified ZN stains were negative.

![Right forelimb improvement after treatment of *Curvularia geniculata* **(a)**; Clinical appearance of cutaneous *Nocardia niigatensis* with diffuse left forelimb edema, nodules and two draining tracts **(a, b)**; Histopathology of cutaneous nocardiosis is characterized by diffuse neutrophilic dermatitis with superficial dermal edema and small numbers of macrophages(**c**: 4X, H&E stain; **d**: 20X, H&E stain); Rare, slender gram-positive branching bacilli (arrowheads) scattered throughout the deep dermis with neutrophilic cell infiltration(**e**: 100X, Gram-stain); Clinical improvement of left forelimb after treatment of cutaneous Nocardiosis **(f)**; Multifocal exophytic cutaneous viral papillomason lateral muzzle **(g)**.](fvets-06-00249-g0002){#F2}

Aerobic bacterial culture of the fresh tissue yielded branching gram-positive bacilli and *Streptomyces* spp. was identified as the causative pathogen by conventional phenotypic bacterial identification methods as well as matrix-absorption laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS). The *Streptomyces* spp. isolate was sensitive to amikacin, trimethoprim-sulfamethoxazole (TMS), and moxifloxacin. *Streptomyces* infection in dogs are rare with concern for a bacterial contaminant ([@B7]). The isolate was subjected to 16S rRNA sequencing using published primers ([@B8]), followed by direct Sanger sequencing of PCR product and GenBankBLASTn searches. Results confirmed the amplified 1,373 bp band sequences to be 100% homologous to the *Nocardia niigatensis* complete 16S rRNA sequence (AB092563). Treatment was initiated with once daily oral enrofloxacin (5 mg/kg; Bayer, Shawnee Mission, KA, USA) and twice daily doxycycline (5 mg/kg; West-Ward Pharmaceuticals, Eatontown, NJ, USA); immunosuppressants MMF (12 mg/kg oncedaily) and prednisone (0.5 mg/kg AM and 0.3 mg/kg PM) were continued.

On progress examination, 3 weeks later (13 weeks from initial presentation), the left forelimb swelling, nodules, and draining tracts improved markedly ([Figure 2f](#F2){ref-type="fig"}), but the patient developed with acute diffuse swelling of the right carpus and several multifocal exophytic cutaneous masses were observed on the face and legs ([Figure 2g](#F2){ref-type="fig"}). Radiographs revealed an aggressive, osteolytic bone lesion of the distal aspect of the right radius. Histopathological examination of the bone biopsy showed productive osteoblastic osteosarcoma. Fungal culture yielded no growth. Surgical removal of the cutaneous masses with histopathology revealed irregular epidermal hyperplasia with intranuclear keratinocyte inclusion bodies characteristic of viral-induced papillomas ([Figures 3a--c](#F3){ref-type="fig"}). Immunosuppression with MMF (12 mg/kg) once daily was continued, prednisone and the previous therapies for *Nocardia* and *Curvularia* infections were discontinued.

![Clinical appearance and histopathology of cutaneous viral exophyticpapillomas. Note the papillary hyperplasia and severe hyperkeratotis (**a**: 4X, H&Estain). Keratinocytes are enlarged with gray-blue finely fibrillar cytoplasm and sometimes have a large amphophilic, intranuclear inclusion body that peripheralizes the chromatin (**b**: 20X, H&E stain); Immunohistochemistry staining with anti-human papillomavirus antibodies reveals the presence of papillomaviral L1 positive for viral papillomas (**c**: 10X; broad spectrum BPV-1/IH8 and CAMVIR-1 antibody). Diffuse to coalescing viral-papillomas on the left forelimb limb and margin of paw pad **(d--f)**; Near regression of viral papillomas of left forelimb after therapy with topical imiquimod **(g)**.](fvets-06-00249-g0003){#F3}

About 4 weeks later, the patient presented with development of diffuse to coalescing viral-papillomas (VP) on the left forelimb ([Figures 3d--f](#F3){ref-type="fig"}). Therapy with every other day topical imiquimod (5%; Perrigo; Allegan, MI, USA) resulted in near regression of the lesions 2 weeks later ([Figure 3g](#F3){ref-type="fig"}). The patient was euthanized 3 weeks later (20 weeks from initial presentation) due to progression of osteosarcoma.

Discussion {#s3}
==========

To the authors\' best knowledge, this is the first case report of successful treatment of cutaneous opportunistic bacterial, fungal and viral infections in a canine patient with continued immunosuppressive therapy for IMHA. This case report confirms the increasing prevalence risk of opportunistic cutaneous infections in immunosuppressed dogs and the therapeutic challenges clinicians encounter when presented with these cases.

Ciclosporin administration is considered a significant risk factor for opportunistic invasive fungal infections (OIFI) in multi-immunosuppressor agent treatment protocols for immune-mediated diseases in dogs ([@B3]). Interestingly, prednisone, MMF, azathioprine, and leflunomide were not associated with the development of OIFI ([@B3]). The majority of dogs with OIFI are diagnosed with phaeohyphomycosis or hyalohyphomycosis; the most common genera of phaeohyphomycosis associated with OIFI includes *Curvularia* species (spp.), *Alternaria* spp., *Bipolaris* spp., *Cladosporium* spp., and *Paraconiothyrium* spp. ([@B2], [@B3], [@B6]). In this report, cutaneous OIFI affecting right forelimb was developed during 6-week multi-agent immunosuppressive protocol for IMHA and *Curvularia geniculata* was identified as a causative agent using next-generation sequencing from the fungal culture. Treatment of dogs that develop cutaneous OIFI, consists of discontinuation of immunosuppressive medications, administration of antifungal medications and surgical excision if lesions are solitary or on a distal extremity ([@B3], [@B6]). Discontinuing ciclosporin administration and reducing the dosage of prednisolone resulted in spontaneous cutaneous phaeohyphomycosis resolution in a single dog while IMHA was controlled in remission ([@B9]). However, in some patients, additional long-term systemic antifungal medications with discontinuation of immunosuppressive medications are needed for the successful OIFI treatment ([@B3], [@B10]). Importantly, systemic antifungal azoles (e.g., itraconazole, ketoconazole, fluconazole) should not be administered to OIFI patients unless ciclosporine is discontinued; systemic azoles increase blood levels of ciclosporine when jointly administered, which leads to more potent immunosuppression ([@B11]). Rapid clinical remission of cutaneous phaeohyphomycosis in our dog was achieved with discontinuation of ciclosporine and administration of systemic combination itraconazole and terbinafine; surgical approach and limb amputation were not needed. Combination antifungal therapy due to the severity of IMHA in our patient, systemic immunosuppression with MMF and prednisone was reduced but continued during the antifungal treatment.

Opportunistic bacterial and viral infections in dogs receiving MMF alone or together with glucocorticoids are not well-documented. The most common side effect in dogs during MMF and glucocorticoid administration for treatment of canine IMHA is diarrhea ([@B12]). Opportunistic cutaneous and systemic infections with *Nocardia* spp. in dogs have been associated with ciclosporine administration ([@B1], [@B13]). Nocardiosis can be difficult to diagnose due to the relatively slow growth of the organism and possible contaminants from tissue samples ([@B1], [@B13]). We removed the superficial part of the skin biopsy tissue to avoid surface skin contaminants in the culture in our dog. The use of MALDI-TOF MS, to identify most bacterial and fungal isolates, has revolutionized workflow and improved turnaround time in clinical microbiology laboratories. From 312 Nocardia isolates tested, 236 (76%) were correctly identified to the species level using MALDI-TOF MS ([@B14]). In our case, MALDI-TOF MS identified the cultured Gram-positive branching bacilli as *Streptomyces* spp; invasive *Streptomyces* infections are uncommon in animals and are sometimes considered to be contaminants ([@B7]). To confirm the MALDI-TOF MS bacterial identification results in our dog, 16S rRNA gene sequencing was performed on the bacterial isolate and revealed *Nocardia niigatensis*; 16S rRNA gene sequencing is commonly used for *Nocardia* identification as the 16S rRNA gene is highly conserved among *Nocardia* species ([@B1]). Identification of the *Nocardia* species as the causative pathogen, involved in our patient\'s skin lesions, is important because it allows different options for an effective systemic antimicrobial therapy. Taking into account the skin lesion severity and the time needed to obtain results from the bacterial culture, histopathology and gene sequencing, our patient was immediately started with oral doxycycline and enrofloxacin. Historically, TMS has been the antimicrobial drug of choice in dogs for its recognized activity against *Nocardia* spp. and low cost; TMS was not utilized in our IMHA patient due to concerns of a potential adverse effect of inducing hemolytic anemia ([@B15]). In this case, treatment with doxycycline and enrofloxacin resulted in significant clinical improvement of cutaneous nocardiosis lesions without adverse effects observed during treatment. Interestingly, tetracyclines are considered as an alternative oral agent for nocardiosis in humans with hypersensitivity to TMS or TMS refractory nocardiosis ([@B16]). Further studies are needed in both human and canine patients to provide additional antibiotic options for treatment of *Nocardia* infections.

Cutaneous PV infections can be developed in dogs without detectable immunodeficiency, are self-limiting and frequently regress spontaneously in one to 12 months ([@B4], [@B5]). Systemic immunosuppression has been associated with the development of PV-induced lesions in dogs ([@B4], [@B5]). Topical imiquimod is an immune modifier that acts by stimulating Th1 cytotoxic cell-mediated immune response ([@B17]). The reports of imiquimod usage in canine PV skin infections are limited; complete resolution of disseminated cutaneous viral papillomatosis with multimodal treatment involving surgical resection, topical imiquimod cream once daily and canine papillomavirus 2 vaccine was achieved in one dog ([@B18]). In our patient, surgical resection was not feasible with the location and severity of skin lesions. Topical imiquimod every other day resulted in significant regression of PV lesions within 2 weeks of therapy without side effects.

The patient developed osteosarcoma during the treatment of IMHA. In humans, IMHA is a known paraneoplastic syndrome but there is lacking veterinary literature linking cancer and IMHA in dogs, but cancer should be considered as a possible trigger to IMHA ([@B19]). Systemic immunosuppression with ciclosporine increases the risk of neoplasia in human transplant recipients with a case report of lymphoma in a canine patient treated with ciclosporine and ketoconazole for anal fistulas ([@B19], [@B20]). Our patient received ciclosporine for 6 weeks during initial treatment of IMHA, but was discontinued with development of an opportunistic fungal infection. In this case report, this breed is at an increased the risk of osteosarcoma development, but the role of immunosuppression in neoplasia development is not known ([@B21], [@B22]). The most recent literature has not reported immunosuppression as a risk factor for the development of osteosarcoma in canine patients ([@B22]).

Conclusions {#s4}
===========

In conclusion, this case represents, to the best of our knowledge, the first description of the successful treatment of cutaneous opportunistic bacterial, fungal and viral infection in an immunosuppressed dog, even though the immunosuppressive drug treatments could not be discontinued. This case highlights the importance of monitoring multi-agent immunosuppressed patients for development of unusual opportunistic infections and pathogen identification with a deep skin biopsy, histopathology, tissue cultures and next-generation sequencing.
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